Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 43

1.

TSC2 loss in lymphangioleiomyomatosis cells correlated with expression of CD44v6, a molecular determinant of metastasis.

Pacheco-Rodriguez G, Steagall WK, Crooks DM, Stevens LA, Hashimoto H, Li S, Wang JA, Darling TN, Moss J.

Cancer Res. 2007 Nov 1;67(21):10573-81.

2.

Keratinocyte-fibroblast interactions in wound healing.

Werner S, Krieg T, Smola H.

J Invest Dermatol. 2007 May;127(5):998-1008. Review.

3.

Identification of novel Wilms' tumor suppressor gene target genes implicated in kidney development.

Kim HS, Kim MS, Hancock AL, Harper JC, Park JY, Poy G, Perantoni AO, Cam M, Malik K, Lee SB.

J Biol Chem. 2007 Jun 1;282(22):16278-87. Epub 2007 Apr 12.

4.

Scratching the surface of skin development.

Fuchs E.

Nature. 2007 Feb 22;445(7130):834-42. Review.

5.

Hitting the mark in hamartoma syndromes.

Darling TN.

Adv Dermatol. 2006;22:181-200. Review.

PMID:
17249302
6.

Epiregulin, a member of the EGF family, is over-expressed in psoriatic epidermis.

Shirakata Y, Kishimoto J, Tokumaru S, Yamasaki K, Hanakawa Y, Tohyama M, Sayama K, Hashimoto K.

J Dermatol Sci. 2007 Jan;45(1):69-72. Epub 2006 Sep 20. No abstract available.

PMID:
16996251
7.

Regulation of amphiregulin and epiregulin expression in human colonic subepithelial myofibroblasts.

Inatomi O, Andoh A, Yagi Y, Bamba S, Tsujikawa T, Fujiyama Y.

Int J Mol Med. 2006 Sep;18(3):497-503.

PMID:
16865236
9.

Tuberous sclerosis complex: linking growth and energy signaling pathways with human disease.

Astrinidis A, Henske EP.

Oncogene. 2005 Nov 14;24(50):7475-81. Review.

PMID:
16288294
10.

Induction of renal tumorigenesis with elevated levels of somatic loss of heterozygosity in Tsc1+/- mice on a Blm-deficient background.

Wilson C, Idziaszczyk S, Colley J, Humphreys V, Guy C, Maynard J, Sampson JR, Cheadle JP.

Cancer Res. 2005 Nov 15;65(22):10179-82.

11.

Tuberous sclerosis: a GAP at the crossroads of multiple signaling pathways.

Kwiatkowski DJ, Manning BD.

Hum Mol Genet. 2005 Oct 15;14 Spec No. 2:R251-8. Review.

PMID:
16244323
12.

The aryl hydrocarbon receptor directly regulates expression of the potent mitogen epiregulin.

Patel RD, Kim DJ, Peters JM, Perdew GH.

Toxicol Sci. 2006 Jan;89(1):75-82. Epub 2005 Sep 28.

PMID:
16192470
13.

MCP-1 overexpressed in tuberous sclerosis lesions acts as a paracrine factor for tumor development.

Li S, Takeuchi F, Wang JA, Fuller C, Pacheco-Rodriguez G, Moss J, Darling TN.

J Exp Med. 2005 Sep 5;202(5):617-24. Epub 2005 Aug 29.

14.

Autocrine regulation of human urothelial cell proliferation and migration during regenerative responses in vitro.

Varley C, Hill G, Pellegrin S, Shaw NJ, Selby PJ, Trejdosiewicz LK, Southgate J.

Exp Cell Res. 2005 May 15;306(1):216-29.

PMID:
15878346
15.

Increase in amphiregulin and epiregulin in prostate cancer xenograft after androgen deprivation-impact of specific HER1 inhibition.

Tørring N, Hansen FD, Sørensen BS, Ørntoft TF, Nexø E.

Prostate. 2005 Jun 15;64(1):1-8.

PMID:
15651060
16.

Pathogenesis of tuberous sclerosis subependymal giant cell astrocytomas: biallelic inactivation of TSC1 or TSC2 leads to mTOR activation.

Chan JA, Zhang H, Roberts PS, Jozwiak S, Wieslawa G, Lewin-Kowalik J, Kotulska K, Kwiatkowski DJ.

J Neuropathol Exp Neurol. 2004 Dec;63(12):1236-42.

PMID:
15624760
17.

A mouse model of cardiac rhabdomyoma generated by loss of Tsc1 in ventricular myocytes.

Meikle L, McMullen JR, Sherwood MC, Lader AS, Walker V, Chan JA, Kwiatkowski DJ.

Hum Mol Genet. 2005 Feb 1;14(3):429-35. Epub 2004 Dec 15.

PMID:
15601645
18.

Pediatric dermatologic surgery: a surgical approach to the cutaneous features of tuberous sclerosis complex.

Sweeney SM.

Adv Dermatol. 2004;20:117-35. Review. No abstract available.

PMID:
15544198
19.

Expression of betacellulin, heparin-binding epidermal growth factor and epiregulin in human malignant fibrous histiocytoma.

Yamamoto T, Akisue T, Marui T, Nakatani T, Kawamoto T, Hitora T, Nagira K, Fujita I, Matsumoto K, Kurosaka M.

Anticancer Res. 2004 May-Jun;24(3b):2007-10.

20.

The tumor microenvironment: a critical determinant of neoplastic evolution.

van Kempen LC, Ruiter DJ, van Muijen GN, Coussens LM.

Eur J Cell Biol. 2003 Nov;82(11):539-48. Review.

PMID:
14703010

Supplemental Content

Support Center